{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:20:26Z","timestamp":1791991226372,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01CA260064"],"award-info":[{"award-number":["1R01CA260064"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5KL2TR001424"],"award-info":[{"award-number":["5KL2TR001424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["RSG-20-050-01"],"award-info":[{"award-number":["RSG-20-050-01"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jid.2022.07.027","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T03:28:24Z","timestamp":1663990104000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3148-8833","authenticated-orcid":false,"given":"Yue","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8935-2165","authenticated-orcid":false,"given":"Tessa M.","family":"LeWitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6707-917X","authenticated-orcid":false,"suffix":"Jr.","given":"Abner","family":"Louissaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-9237","authenticated-orcid":false,"given":"Joan","family":"Guitart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-2472","authenticated-orcid":false,"given":"Xiaolong Alan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-2226","authenticated-orcid":false,"given":"Jaehyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2022.07.027_bib1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/modpathol.3880398","article-title":"Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases","volume":"14","author":"Aguilera","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib2","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: a case report","volume":"12","author":"Al-Obaidi","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jid.2022.07.027_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.leu.2401708","article-title":"Lack of CD95\/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas","volume":"14","author":"Bertoni","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.jid.2022.07.027_bib4","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/bloodadvances.2020002371","article-title":"Pembrolizumab in mycosis fungoides with PD-L1 structural variants","volume":"5","author":"Beygi","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jid.2022.07.027_bib5","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jid.2018.03.1516","article-title":"A\u00a0single-arm Phase II trial of lenalidomide in relapsing or refractory primary cutaneous large B-cell lymphoma, leg type","volume":"138","author":"Beylot-Barry","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib6","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","article-title":"Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression","volume":"26","author":"Brenner","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2022.07.027_bib8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/PAS.0000000000001363","article-title":"Class-switched primary cutaneous marginal zone lymphomas are frequently IgG4-positive and have features distinct from IgM-positive cases","volume":"43","author":"Carlsen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"Suppl","key":"10.1016\/j.jid.2022.07.027_bib11","first-page":"S38","article-title":"Primary cutaneous marginal zone B-cell lymphoma","volume":"125","author":"Cho-Vega","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093903","article-title":"Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component","volume":"9","author":"Cox","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2022.07.027_bib13","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib14","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/ijms19061758","article-title":"Molecular mechanisms of disease progression in primary cutaneous diffuse large B-cell lymphoma, leg type during ibrutinib therapy","volume":"19","author":"Fox","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jid.2022.07.027_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-018-2384-3","article-title":"Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein","volume":"473","author":"G\u00e1ng\u00f3","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jid.2022.07.027_bib16","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood-2016-08-733469","article-title":"Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice","volume":"129","author":"Garc\u00eda-Ram\u00edrez","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib17","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib18","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France","volume":"150","author":"Grange","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib19","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.4081\/rt.2015.6067","article-title":"Excellent outcome of immunomodulation or bruton's tyrosine kinase inhibition in highly refractory primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"7","author":"Gupta","year":"2015","journal-title":"Rare Tumors"},{"key":"10.1016\/j.jid.2022.07.027_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.0022-202X.2004.22720.x","article-title":"Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas","volume":"123","author":"Hallermann","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","article-title":"Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience","volume":"87","author":"Hamilton","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jid.2022.07.027_bib22","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib23","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1002\/cam4.2316","article-title":"Comparison of PD-L1 detection assays and corresponding significance in evaluation of diffuse large B-cell lymphoma","volume":"8","author":"Huang","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jid.2022.07.027_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrc.2017.127","article-title":"From genetics to the clinic: a translational perspective on follicular lymphoma","volume":"18","author":"Huet","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2022.07.027_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/2040620712453595","article-title":"Marginal zone lymphoma: old, new, targeted, and epigenetic therapies","volume":"3","author":"Joshi","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.jid.2022.07.027_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jid.2022.07.027_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jid.2013.265","article-title":"Nuclear factor-\u03baB pathway-activating gene aberrancies in primary cutaneous large B-cell lymphoma, leg type","volume":"134","author":"Koens","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.1401917","article-title":"CD58\/CD2 is the primary Costimulatory pathway in human CD28-CD8+ T cells","volume":"195","author":"Leitner","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2022.07.027_bib29","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/cam4.865","article-title":"Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: comparison with current classification and definition of prognostic markers","volume":"5","author":"Lucioni","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.jid.2022.07.027_bib30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3324\/haematol.2013.085548","article-title":"Nature and importance of follicular lymphoma precursors","volume":"99","author":"Mamessier","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jid.2022.07.027_bib31","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib32","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","article-title":"Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma","volume":"138","author":"Maurus","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib33","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/his.13832","article-title":"Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases","volume":"74","author":"Menguy","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.jid.2022.07.027_bib34","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 somatic mutation is a diagnostic criterion in primary cutaneous large B-cell lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PAS.0000000000000983","article-title":"PD-L1 and PD-L2 are differentially expressed by macrophages or tumor cells in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Menguy","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.immuni.2019.05.022","article-title":"The HVEM-BTLA axis restrains T cell help to germinal center B cells and functions as a cell-extrinsic suppressor in lymphomagenesis","volume":"51","author":"Mintz","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.07.027_bib37","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2002.20.3.647","article-title":"Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features","volume":"20","author":"Mirza","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jid.2022.07.027_bib38","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/PAS.0000000000000851","article-title":"Tumor microenvironment and checkpoint molecules in primary cutaneous diffuse large B-cell lymphoma-new therapeutic targets","volume":"41","author":"Mitteldorf","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib39","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2017-01-764209","article-title":"PD-1 blockade with nivolumab in relapsed\/refractory primary central nervous system and testicular lymphoma","volume":"129","author":"Nayak","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","article-title":"High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"150","author":"Pham-Ledard","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib41","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","article-title":"MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"132","author":"Pham-Ledard","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Pham-Ledard","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2013.156","article-title":"Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma","volume":"27","author":"Pham-Ledard","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jdermsci.2017.07.008","article-title":"Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"88","author":"Pham-Ledard","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2022.07.027_bib45","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2019.07.001","article-title":"Class-switch recombination occurs infrequently in germinal centers","volume":"51","author":"Roco","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2022.07.027_bib46","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1084\/jem.20061292","article-title":"Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis [published correction appears in J Exp Med 2006;203:2563","volume":"203","author":"Roulland","year":"2006","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2022.07.027_bib47","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2022.07.027_bib48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-021-03265-5","article-title":"Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas","volume":"480","author":"Schrader","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jid.2022.07.027_bib49","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/PAS.0000000000001132","article-title":"High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Schrader","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jid.2022.07.027_bib50","first-page":"91","article-title":"Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma","volume":"10","author":"Schreuder","year":"2017","journal-title":"J\u00a0Hematop"},{"key":"10.1016\/j.jid.2022.07.027_bib51","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ijc.23958","article-title":"Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals","volume":"124","author":"Sch\u00fcler","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jid.2022.07.027_bib52","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification","volume":"69","author":"Su\u00e1rez","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib55","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1172\/JCI79189","article-title":"Follicular lymphoma: too many reminders for a memory B cell","volume":"124","author":"Swaminathan","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2022.07.027_bib56","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1182\/blood-2013-12-545954","article-title":"Human T(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis?","volume":"123","author":"Tellier","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib57","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib58","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","article-title":"Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin","volume":"480","author":"Vela","year":"2022","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jid.2022.07.027_bib59","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.2020005857","article-title":"The dangers of d\u00e9j\u00e0 vu: memory B cells as the cells of origin of ABC-DLBCLs","volume":"136","author":"Venturutti","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib60","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.3390\/cancers12102913","article-title":"Oncogenic mutations of MYD88 and CD79B in diffuse large B-cell lymphoma and implications for clinical practice","volume":"12","author":"Visco","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jid.2022.07.027_bib61","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.3324\/haematol.2020.254854","article-title":"Genetic evolution of in situ follicular neoplasia to aggressive B-cell lymphoma of germinal center subtype","volume":"106","author":"Vogelsberg","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jid.2022.07.027_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-11-0208","article-title":"Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation","volume":"2","author":"Weigert","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jid.2022.07.027_bib63","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas [published correction appears in Blood 2019;134:1112]","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jid.2022.07.027_bib64","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/bjd.15183","article-title":"Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal-zone lymphoma with a nonclass-switched immunoglobulin M immunophenotype","volume":"177","author":"Wobser","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib65","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2022.07.027_bib66","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jid.2018.04.038","article-title":"Genomic analyses identify recurrent alterations in immune evasion genes in diffuse large B-cell lymphoma, leg type","volume":"138","author":"Zhou","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2022.07.027_bib67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jid.2022.07.027_bib68","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22018875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X22018875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T17:30:11Z","timestamp":1758303011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X22018875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0022202X22018875"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2022.07.027","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2022.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}